Drug Type ASO |
Synonyms XNA 19A0, XNA19A0 |
Target |
Action modulators |
Mechanism TAU modulators(Microtubule-associated protein tau modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | China | 01 Apr 2025 |